Care Access - New Iberia — New Iberia, Louisiana

Care Access - New Iberia is a clinical research site located in New Iberia, Louisiana, United States 70560.

Crixeo Clinical Trials Trust Score: 17/100 (FAILING). This profile has not yet been claimed by the site owner.

Care Access - New Iberia has participated in 8 clinical trials with 8 currently active.

Therapeutic areas: Obesity, Overweight, Type 2 Diabetes.

Sponsors: Eli Lilly and Company, Sanofi.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in New Iberia

Browse all research sites in Louisiana · View every site in New Iberia

• Pfizer Investigational Site
• Louisiana Oncology Associates
• Atea Study Site
• Cardiovascular Institute of the South
• GSK Investigational Site
• Headache and Pain Ctr
• 502.550.01011 Boehringer Ingelheim Investigational Site
• Research Site
• 1160.63.01044 Boehringer Ingelheim Investigational Site
• Research Facility
• Acadiana Renal Physicians

Sponsor Feasibility Report

Trust Score: 17/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Care Access - New Iberia?

Care Access - New Iberia has a Crixeo Trust Score of 17/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Care Access - New Iberia conducted?

Care Access - New Iberia has 8 clinical trials on record, with 8 currently active. Their work covers Obesity, Overweight, Type 2 Diabetes.

Is Care Access - New Iberia accredited by Crixeo Clinical Trials?

Care Access - New Iberia has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Care Access - New Iberia?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.